Erin, 3 years old, was diagnosed with a brain tumor.  After surgery, her parents had to choose from two forms of chemotherapy: one already available and a newer one only available through a “clinical trial”.  Her parents went onto the Internet to look for information on these treatments but found the information inconsistent, confusing and they were unsure of its accuracy.

CMR sent Erin’s parents a current, comprehensive research report on this kind of brain cancer and the treatment options available.  This information included up to date information on the chemotherapy currently available and the clinical trial.  The clinical trials information included success rates and side effects of the new drug and how it compared with the other chemotherapy.

After reading the report and discussing it with their doctor, Erin’s parents chose the clinical trial because the preliminary data showed it was superior to the older treatment in that it had fewer side effects and was more effective.  Erin’s parents feel they made an informed choice and the best decision possible.